RT @AnGeLaUyEn: El cierre d servicios, reducción d RH, etc dejaron a muchos pacientes esperando atención quirúrgica complicándose en la esp…
RT @AnGeLaUyEn: El cierre d servicios, reducción d RH, etc dejaron a muchos pacientes esperando atención quirúrgica complicándose en la esp…
El cierre d servicios, reducción d RH, etc dejaron a muchos pacientes esperando atención quirúrgica complicándose en la espera. Una estrategia es mantener hospitales "limpios" de COVID para cirugía (no emergencia) q evite estás esperas y complicaciones htt
RT @SOuRCe_RPA: Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology @RPA_IAS @SOuRCe_RPA @nature…
RT @SOuRCe_RPA: Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology @RPA_IAS @SOuRCe_RPA @nature…
“… any limitations or delays in access [to surgery] while health-care efforts are shifted towards managing the pandemic will inevitably result in collateral mortality”
Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology @RPA_IAS @SOuRCe_RPA @nature https://t.co/QtbzCes08i
RT @weoncologists: Just out📣at @NatRevClinOncol 📰commentary highlighting the potential problem of ‘collateral mortality’ from delayed/defer…
RT @LukeRothermel: Delays in cancer care during this pandemic are expected to lead to ‘collateral mortality’ from these diseases. The multi…
RT @weoncologists: Just out📣at @NatRevClinOncol 📰commentary highlighting the potential problem of ‘collateral mortality’ from delayed/defer…
Delays in cancer care during this pandemic are expected to lead to ‘collateral mortality’ from these diseases. The multidisciplinary teams @UHhospitals @caseccc consider these risks for all patients presenting for cancer care. @UHSurgOncology
RT @weoncologists: Just out📣at @NatRevClinOncol 📰commentary highlighting the potential problem of ‘collateral mortality’ from delayed/defer…
RT @weoncologists: Just out📣at @NatRevClinOncol 📰commentary highlighting the potential problem of ‘collateral mortality’ from delayed/defer…
RT @weoncologists: Just out📣at @NatRevClinOncol 📰commentary highlighting the potential problem of ‘collateral mortality’ from delayed/defer…
RT @weoncologists: Just out📣at @NatRevClinOncol 📰commentary highlighting the potential problem of ‘collateral mortality’ from delayed/defer…
RT @weoncologists: Just out📣at @NatRevClinOncol 📰commentary highlighting the potential problem of ‘collateral mortality’ from delayed/defer…
RT @mtmdphd: Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology [May 5, 2020] Tan, Moran & Solom…
RT @mtmdphd: Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology [May 5, 2020] Tan, Moran & Solom…
Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology [May 5, 2020] Tan, Moran & Solomon @NatRevClinOncol https://t.co/2VYcQcHLXA #surgonc #COVID19 #CCC19 #COVID19nCancer HT @ADesaiMD
RT @weoncologists: Just out📣at @NatRevClinOncol 📰commentary highlighting the potential problem of ‘collateral mortality’ from delayed/defer…
RT @weoncologists: Just out📣at @NatRevClinOncol 📰commentary highlighting the potential problem of ‘collateral mortality’ from delayed/defer…
RT @weoncologists: Just out📣at @NatRevClinOncol 📰commentary highlighting the potential problem of ‘collateral mortality’ from delayed/defer…
Just out📣at @NatRevClinOncol 📰commentary highlighting the potential problem of ‘collateral mortality’ from delayed/deferred treatments🧪due to #COVID19 🦠in patients w/ #cancer ‼️https://t.co/j9RlYrzJ5d https://t.co/z5sUImdDMr
RT @mtmdphd: Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology [May 5, 2020] Tan, Moran & Solom…
New Comment by Ker-Kan Tan, Brendan Moran & Michael Solomon: 'Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology' - https://t.co/lFRjIfvylr #COVID19 #COVID19nCancer https://t.co/ti6ZPjEl2A
RT @ADesaiMD: @NatRevClinOncol article addressing ‘collateral mortality’ from delayed or deferred treatments in patients with #cancer in #C…
Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology https://t.co/klIx1iZeEv https://t.co/Vw9D1eXLU8
RT @DrYukselUrun: Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology! #COVID19 @NatRevClinOncol…
RT @ADesaiMD: @NatRevClinOncol article addressing ‘collateral mortality’ from delayed or deferred treatments in patients with #cancer in #C…
Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology! #COVID19 @NatRevClinOncol @OncoAlert https://t.co/dazkhW5ZGN https://t.co/Jr0AXJj8TE
RT @mtmdphd: Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology [May 5, 2020] Tan, Moran & Solom…
RT @mtmdphd: Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology [May 5, 2020] Tan, Moran & Solom…
Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology [May 5, 2020] Tan, Moran & Solomon @NatRevClinOncol https://t.co/2VYcQcHLXA #surgonc #COVID19 #CCC19 #COVID19nCancer HT @ADesaiMD https://t.co/Smipb3lgRH
RT @ADesaiMD: @NatRevClinOncol article addressing ‘collateral mortality’ from delayed or deferred treatments in patients with #cancer in #C…
RT @ADesaiMD: @NatRevClinOncol article addressing ‘collateral mortality’ from delayed or deferred treatments in patients with #cancer in #C…
RT @ADesaiMD: @NatRevClinOncol article addressing ‘collateral mortality’ from delayed or deferred treatments in patients with #cancer in #C…
RT @ADesaiMD: @NatRevClinOncol article addressing ‘collateral mortality’ from delayed or deferred treatments in patients with #cancer in #C…
@NatRevClinOncol article addressing ‘collateral mortality’ from delayed or deferred treatments in patients with #cancer in #COVID19 era, with potential solutions to ensure continuity of care in the field of #surgicaloncology #CCC19 #COVID19nCancer: https:/